If monthly manipulation is to keep on occuring, is it in the best interests of shareholders to continue with this funding arrangement? We are not bound to them in any way, and can seek finance elsewhere if Im not mistaken? Given that the Dendreon decision has derisked Prima to a certain extent, I think that in the interests of shareholders and the Company, alternative funding should be strongly sought! Maybe that is what Martin Rogers is doing at the Bio Conference this week? I sure hope so. If it werent for this blatant manipulation(is it even legal), IMO the SP would be a LOT higher!
What are your thoughts?
PRR Price at posting:
16.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)